Hi ,

Big news this week—Dean Kamen, one of the most influential inventors of our time, is taking the stage at SynBioBeta 2025! From medical robotics to tissue engineering, his impact on biotech is undeniable. Also just announced: our Pre-Conference Attendee Zoom Call on March 26—your chance to get insider details before the event kicks off.

This week in the news, discover how RNA-based cells are redefining synthetic life, MIT’s 3D-printed muscles mimic real movement, and a robotic platform is unlocking nature’s hidden pharmaceuticals. Plus, don’t miss our deep dive into Galactic Gastronomy—how synthetic biology could transform food production for space travel and help sustain life beyond Earth. And, in additional industry news, Arbor Biotech raises $73.9M for gene editing, Windfall Bio makes Fast Company’s Most Innovative List, and the latest in biotech funding, leadership changes, and more!

Enjoy your week and there are only 6 weeks left so buy your Conference Ticket today!

Just Announced!

Dean Kamen, Founder & President of DEKA Research & Development, is one of the most influential inventors and entrepreneurs of our time—and he’s taking the stage! From medical breakthroughs like the LUKE robotic arm and HomeChoice™ dialysis machine to leading ARMI BioFabUSA in revolutionizing tissue and organ manufacturing, Dean’s impact is everywhere.

This is a must-see moment at SynBioBeta 2025, May 5-8 in San Jose. Check out our agenda!

Join us for an exclusive Pre-Conference Attendee Zoom Call on March 26 at 8 AM PT!

This is your chance to get insider details on the agenda, networking events, and must-see sessions, plus have all your questions answered before we kick off SynBioBeta 2025: The Global Synthetic Biology Conference in just six weeks.

Click Here to register.

Here are Some of the Currently Registered Companies Who You Can Meet and Collaborate With at SynBioBeta 2025:
Amazon, Estee Lauder, REI, Ginkgo Bioworks, Arsenal Biosciences, Metagenomi, Neoplants, Codexis, Arzeda, Invizyne Technologies, New England Biolabs, BioMADE, Concerto Biosciences, Allozymes, Biomatter Designs, Moonwalk Biosciences, Pylum Biosciences, A-Alpha Bio, Evolutor, Cascade Biocatalysts, Industrial Microbes, DAB.bio, Anthology Bio, Invaio Sciences, Robigo, SilicoLife, Twig Bio, Elicit, Sofinnova Partners, Bayer, Caravel Bio, Xylogenics, and Cell Bauhaus.

Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!

Interested in Sponsoring or Exhibiting? Click here for more information, or contact Anissa Cooke

Galactic Gastronomy: The Science of Producing Food Beyond Earth

Technologies for resource-efficient and sustainable food production have implications for both our space ambitions and growing food on Earth.

Synthetic Biology’s Next Leap: RNA-Based Cells That Build Themselves Without Proteins

By leveraging RNA origami, researchers have created self-assembling cell structures, inching closer to fully synthetic life.

Engineered Muscles That Move Like the Real Thing? MIT Just Made It Happen

Researchers have developed a way to 3D-print muscle tissue that contracts in multiple directions, opening new possibilities for soft robotics and medical applications.

The Race to Automate Nature’s Hidden Pharmacies

Scientists unleash FAST-NPS, a robotic powerhouse that rapidly discovers nature’s hidden bioactive treasures.

The Future of Spinal Cord Injury Treatment: How Cellino and Matricelf Are Leading the Way

Cellino’s Nebula™ technology is powering Matricelf’s autologous 3D differentiation process, bringing scalable regenerative therapies to spinal cord injury patients.